hardcastle
Member
- Reaction score
- 0
I just ran across this article:
http://www.hairdoc.com/book/chapter17.html
"There will still be some problems associated with cloning. One is an increased risk of cancer. The growth-inducing chemicals such as tetradecanoylphorbol acetate (TPA) used to stimulate cellular proliferation for cloning frequently promote tumors and cancer. While cancer risk is low for most cloned cell products, cloning hair follicle stem cells is riskier.
Dermatologists have observed that many basal cell carcinomas, a type of skin cancer that is the most common human tumor, seem to originate from the hair follicle. Cotsarelis notes in the 2000 paper presented in "Dermatology Focus": "the fact that that basal cell carcinomas are slow-growing tumors composed of poorly differentiated cells that have the ability to differentiate into various adnexal structures strongly suggests that the cell of origin is a pluripotent, slowly cycling stem cell with a highly proliferative potential." What he's saying is that molecular and genetic evidence points to the hair follicle stem cell as the source for this common form of cancer. Cloning hair follicle stem cells with cancer-inducing chemicals will require many years of study to assure the safety of the cloned follicles that result."
Thoughts? I'm not trying to dash any hopes, because I'd like to see a solution as much as anyone else. But this sounds like a potentially serious - and not easily detectable - problem.
http://www.hairdoc.com/book/chapter17.html
"There will still be some problems associated with cloning. One is an increased risk of cancer. The growth-inducing chemicals such as tetradecanoylphorbol acetate (TPA) used to stimulate cellular proliferation for cloning frequently promote tumors and cancer. While cancer risk is low for most cloned cell products, cloning hair follicle stem cells is riskier.
Dermatologists have observed that many basal cell carcinomas, a type of skin cancer that is the most common human tumor, seem to originate from the hair follicle. Cotsarelis notes in the 2000 paper presented in "Dermatology Focus": "the fact that that basal cell carcinomas are slow-growing tumors composed of poorly differentiated cells that have the ability to differentiate into various adnexal structures strongly suggests that the cell of origin is a pluripotent, slowly cycling stem cell with a highly proliferative potential." What he's saying is that molecular and genetic evidence points to the hair follicle stem cell as the source for this common form of cancer. Cloning hair follicle stem cells with cancer-inducing chemicals will require many years of study to assure the safety of the cloned follicles that result."
Thoughts? I'm not trying to dash any hopes, because I'd like to see a solution as much as anyone else. But this sounds like a potentially serious - and not easily detectable - problem.